Skip to content
lifestyle.xbode.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Shattuck Labs, Inc.
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
June 5, 2026
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
March 5, 2026
Shattuck Labs Announces Participation in Upcoming March Investor Conferences
February 25, 2026
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
February 11, 2026